Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Heatwaves
Wimbledon Championships
Independence Day
Artificial Intelligence
Social Media
Senate
Taxes
Republican Party
Donald Trump
Soccer
Education
Stock Markets
MedCity News image

News from MedCity News

If you want to know if MedCity News is credible or reliable, look no further. We rank MedCity News as High factuality. Find out more about our methodology here.

Information about MedCity News

Where is MedCity News located?MedCity News's Website

Media Bias Ratings

Average Bias Rating:
Center
Center
byAd Fontes Media
Center
byMedia Bias/Fact Check
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top MedCity News News

Supreme Court endorses Obamacare panel that requires free preventive care
Obamacare · United States

Supreme Court endorses Obamacare panel that requires free preventive care

56% Center coverage: 147 sources
The Supreme Court on Friday rejected a challenge to an Affordable Care Act provision that set up a panel to recommend preventive care services that insurers must provide at no cost to patients.See the Story
Health insurers promise to improve coverage reviews that prompt delays and complaints
Health · United States

Health insurers promise to improve coverage reviews that prompt delays and complaints

68% Center coverage: 118 sources
See the Story
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Novo Nordisk · United States

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

62% Center coverage: 73 sources
Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient...See the Story

AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology

100% Center coverage: 3 sources
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. ("Capstan"), a clinical-stage biotechnology company dedicated to advancing in vivo...StartupsSee the Story

FDA Just Made Some Key Regulatory Changes to Make Cancer Cell Therapies More Accessible

67% Center coverage: 3 sources
The FDA has eliminated a safety monitoring requirement and eased certain restrictions that had been in place since CAR T-therapies first reached the market in 2017. The agency and financial analysts say the changes should improve patient access to these personalized cancer treatments.United States · United StatesSee the Story

MedCity FemFwd: Inside Springboard Enterprises and Accenture's New Women's Health Report

100% Center coverage: 1 sources
In this episode, we’re joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women’s health report. The post MedCity FemFwd: Inside Springboard Enterprises and Accenture’s New Women’s Health Report appeared first on MedCity News.United States · United StatesRead Article

The Critical Role of Technology and Data Sharing in Public Health Emergencies

100% Center coverage: 1 sources
We have an imperative to restore trust in science and continue to advance equity, and we have the means to do so with technology, data connections, and dedicated healthcare professionals. It is also critically important to preserve our expert scientific and public health resources so they can ensure we are prepared for the next crisis. The post The Critical Role of Technology and Data Sharing in Public Health Emergencies appeared first on MedCit…ScienceRead Article

Why Employers Think the 340B Program Needs Reform

100% Center coverage: 1 sources
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to “buy low and sell high” by purchasing discounted medications and charging insured patients full price. The post Why Employers Think the 340B Program Needs Reform appeared first on MedCity News.United States · United StatesRead Article

BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal

100% Center coverage: 1 sources
Neopharmed Gentili is acquiring European rights to Orladeyo, bringing the Italy-based pharmaceutical company into rare disease. BioCryst’s Orladeyo is approved for treating patients with the rare disease hereditary angioedema. The post BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal appeared first on MedCity News.Pharma · ItalySee the Story

No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net

100% Center coverage: 1 sources
Through the convergence of proactive policy, advanced technology and strategic public-private partnerships, we can achieve this “no wrong door” vision and deliver a connected, streamlined social safety net that’s more efficient, economical, and effective. Here’s how. The post No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net appeared first on MedCity News.EconomySee the Story

The Administration’s Autism Plan Is Controversial – But It Also Presents a Vital Opportunity

100% Center coverage: 1 sources
Public debate is growing, but the real path forward lies in defining autism’s biology — and for the first time, we can. The post The Administration’s Autism Plan Is Controversial – But It Also Presents a Vital Opportunity appeared first on MedCity News.AutismSee the Story

Breaking News Topics Related to MedCity News

Artificial Intelligence icon

Artificial Intelligence

Health icon

Health

Medical icon

Medical

United States icon

United States

News
For You
SearchBlindspotLocal